By: Heather Easterling and Andrew Wilson
Read time: 1 minute
Since 2020, drug manufacturers have implemented policies restricting the purchase of 340B-priced drugs for covered entities when dispensing through contract pharmacies and the result is contributing to financial losses for safety-net hospitals.
Watch the 340B Tips, Tricks, and Traps webinar as we explore this ever-changing environment and how transparency is at the center of it all.
Share
Post
Post
Email